BIOPHARMACEUTICS & DRUG DISPOSITION

Scope & Guideline

Transforming Insights into Therapeutic Solutions

Introduction

Delve into the academic richness of BIOPHARMACEUTICS & DRUG DISPOSITION with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN0142-2782
PublisherWILEY
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1979 to 2024
AbbreviationBIOPHARM DRUG DISPOS / Biopharm. Drug Dispos.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address111 RIVER ST, HOBOKEN 07030-5774, NJ

Aims and Scopes

The journal 'Biopharmaceutics & Drug Disposition' focuses on the intricate relationships between drug formulation, absorption, metabolism, and the pharmacokinetics/pharmacodynamics of therapeutic agents. It aims to provide a platform for research that advances the understanding of drug disposition in biological systems, particularly through innovative modeling approaches.
  1. Pharmacokinetics and Pharmacodynamics:
    The journal emphasizes studies that explore the pharmacokinetic and pharmacodynamic profiles of drugs, including their absorption, distribution, metabolism, and excretion (ADME) characteristics in various populations and conditions.
  2. Physiologically-Based Pharmacokinetic (PBPK) Modeling:
    A significant focus is on the development and application of PBPK models to predict drug behavior across different species and populations, facilitating better drug development and personalized medicine.
  3. Drug-Drug Interactions and Metabolism:
    Research on the interactions between drugs, particularly those mediated by metabolic enzymes and transporters, is a core area of interest, providing insights into safety and efficacy.
  4. Biopharmaceutical Characterization:
    The journal publishes studies on the biopharmaceutical properties of drug formulations, including novel drug delivery systems and their impact on pharmacokinetics.
  5. Clinical Applications and Case Studies:
    It also includes clinical studies that illustrate the application of pharmacokinetic principles in real-world settings, particularly in special populations such as pediatrics and the elderly.
The journal has been responsive to emerging trends in drug disposition research, with a significant increase in publications addressing innovative methodologies and contemporary issues in pharmacokinetics and drug delivery.
  1. Integration of Artificial Intelligence and Machine Learning:
    Recent publications show a growing trend in the application of AI and machine learning techniques to enhance drug development processes, particularly in predicting pharmacokinetic behaviors.
  2. Focus on Special Populations:
    There is an increasing emphasis on pharmacokinetics in special populations, including pediatrics, geriatrics, and patients with comorbidities, reflecting a broader understanding of individualized therapy.
  3. In Vitro-In Vivo Extrapolation (IVIVE) Studies:
    The use of IVIVE approaches to predict human pharmacokinetics from animal data is trending, which aligns with the need for more efficient drug development pathways.
  4. Advancements in Drug Delivery Systems:
    Innovative drug delivery methods, such as nanotechnology and sustained-release formulations, are gaining prominence, focusing on improving bioavailability and therapeutic outcomes.
  5. Environmental and Ecological Pharmacokinetics:
    Emerging research is increasingly exploring the pharmacokinetics of drugs in environmental contexts, addressing concerns related to drug residues and ecological impacts.

Declining or Waning

While the journal has established a strong repertoire in certain research areas, some themes have seen a decline in focus over recent years. This may be indicative of shifting research priorities or advancements in technology that have rendered previous approaches less relevant.
  1. Traditional Drug Metabolism Studies:
    There has been a noticeable decrease in the publication of studies solely focused on traditional in vitro drug metabolism assays, as newer methodologies such as PBPK modeling become more prevalent.
  2. General Population Pharmacokinetics:
    Research centered on general population pharmacokinetics without consideration for specific subpopulations (like pediatrics or geriatrics) appears to be waning, reflecting a shift towards more tailored pharmacokinetic studies.
  3. Basic Mechanistic Studies without Clinical Relevance:
    Papers that do not bridge the gap between basic mechanistic studies and clinical relevance are becoming less common, as the journal emphasizes translational research that directly impacts clinical practice.

Similar Journals

CLINICAL PHARMACOKINETICS

Transforming Pharmacological Research into Practice
Publisher: ADIS INT LTDISSN: 0312-5963Frequency: 12 issues/year

CLINICAL PHARMACOKINETICS, published by ADIS INT LTD, is a premier journal dedicated to the field of pharmacology, with a distinguished reputation since its inception in 1976. With an impressive impact factor and categorized in the Q1 quartile for both general pharmacology and medical pharmacology, this journal ranks #29 out of 272 and #53 out of 313 in its respective categories in Scopus, highlighting its high academic influence and the quality of research it publishes. CLINICAL PHARMACOKINETICS serves as a vital resource for researchers, professionals, and students interested in the latest advancements in drug metabolism, therapeutic efficacy, and clinical applications of pharmacokinetic studies. As it continues to evolve through 2024 and beyond, the journal remains committed to fostering a deeper understanding of pharmacotherapy and its implications in clinical practice. While it does not currently offer open access, the journal ensures that cutting-edge research is accessible through various academic platforms.

CPT-Pharmacometrics & Systems Pharmacology

Innovating the landscape of pharmacometrics for better health outcomes.
Publisher: WILEYISSN: 2163-8306Frequency: 12 issues/year

CPT-Pharmacometrics & Systems Pharmacology, published by WILEY, is a leading open access journal dedicated to advancing the fields of pharmacometrics and systems pharmacology. Since its inception in 2012, it has established itself as a vital resource for researchers and practitioners, boasting a remarkable impact factor and occupying prestigious Q1 quartiles in categories such as Cardiology and Cardiovascular Medicine, Modeling and Simulation, and Pharmacology (Medical). The journal covers a broad spectrum of topics aimed at enhancing the understanding of drug development, efficacy, and patient safety through innovative modeling and simulation approaches. With its consistent ranking in the top tiers of its field, CPT-Pharmacometrics & Systems Pharmacology provides invaluable insights and fosters scholarly dialogue among its audience, including researchers, educators, and students. The journal is accessible to all, promoting knowledge dissemination and collaborative growth in the pharmacology community.

International Journal of Pharmacology

Connecting Laboratory Discoveries to Clinical Practice
Publisher: ASIAN NETWORK SCIENTIFIC INFORMATION-ANSINETISSN: 1811-7775Frequency: 8 issues/year

Welcome to the International Journal of Pharmacology, a key publication in the field of pharmacology, published by ASIAN NETWORK SCIENTIFIC INFORMATION (ANSINET). Since its inception in 2006, this journal has provided a vital platform for researchers and professionals to disseminate their findings and insights in pharmacology, toxicology, and pharmaceutics. Despite recent discontinuation in Scopus coverage, the journal's dedication to fostering scientific dialogue continues to attract contributions from esteemed scholars globally. With an **ISSN of 1811-7775** and **E-ISSN of 1812-5700**, the journal seeks to bridge the gap between laboratory research and clinical application, promoting a deeper understanding of drug actions and interactions. Although it operates under traditional access options, the relevance of its published studies to ongoing pharmacological research remains significant.

DRUG METABOLISM REVIEWS

Connecting scholars to the forefront of drug science.
Publisher: TAYLOR & FRANCIS LTDISSN: 0360-2532Frequency: 4 issues/year

Drug Metabolism Reviews is a premier journal dedicated to the dissemination of scientific research and reviews in the field of pharmacology, toxicology, and pharmaceutics, published by Taylor & Francis Ltd. With its inception dating back to 1972, this journal has consistently provided an authoritative platform for scholars and professionals from diverse disciplines to explore the intricate mechanisms of drug metabolism and their implications for therapeutic applications. The journal enjoys commendable rankings, placing in the Q2 quartile for Pharmacology (medical) and the Q1 quartile in the miscellaneous subfield, signaling its significant impact within the community. Notably, it is recognized within the top 96th percentile in General Pharmacology, Toxicology and Pharmaceutics, affirming its esteemed position among academic publications. Although it operates under a subscription model, Drug Metabolism Reviews remains an essential resource for researchers, professionals, and students seeking to deepen their understanding of drug interactions, safety, and efficacy. The insights shared within its pages contribute vital knowledge to the global discourse on drug development and personalized medicine.

DRUG METABOLISM AND DISPOSITION

Advancing the Science of Drug Metabolism
Publisher: AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICSISSN: 0090-9556Frequency: 12 issues/year

Drug Metabolism and Disposition is a premier journal published by the American Society for Pharmacology and Experimental Therapeutics, focusing on crucial advancements in the fields of pharmaceutical sciences and pharmacology. Since its inception in 1973, this esteemed journal has established itself as a leading platform for innovative research, earning a prestigious Q1 rating in both Pharmaceutical Science and Pharmacology categories as of 2023. With an impressive Scopus ranking of #52 out of 183 in Pharmaceutical Science and #105 out of 313 in Pharmacology, it occupies a vital place in an increasingly competitive academic landscape. Researchers, professionals, and students alike benefit from its rigorous peer-reviewed articles that delve into drug metabolism processes and their physiological implications, making it an indispensable resource for anyone aiming to advance their understanding of drug disposition and efficacy. This crucial journal contributes significantly to the ongoing dialogue in pharmacology and toxicology, providing insights that help shape future therapeutic strategies and regulatory policies.

CANCER CHEMOTHERAPY AND PHARMACOLOGY

Transforming cancer care with cutting-edge pharmacological insights.
Publisher: SPRINGERISSN: 0344-5704Frequency: 12 issues/year

Cancer Chemotherapy and Pharmacology, published by Springer, is a leading peer-reviewed journal that plays a crucial role in the field of cancer research and drug therapy. With an ISSN of 0344-5704 and an E-ISSN of 1432-0843, this journal has been a cornerstone of oncology and pharmacology research since its inception in 1978, with continued relevance through to 2024. The journal holds a commendable Q2 ranking in categories such as Cancer Research, Oncology, and Pharmacology (medical), while achieving an elite Q1 status in Toxicology, reflecting its high-impact contributions to the scientific community. Researchers and professionals benefit from access to cutting-edge studies, insightful reviews, and innovative methodologies, making it a vital resource for anyone working at the intersection of pharmacology and oncology. Although not an open-access journal, Cancer Chemotherapy and Pharmacology remains highly accessible through institutional subscriptions, ensuring it reaches a broad audience dedicated to advancing cancer treatment and patient care.

JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS

Exploring the Dynamics of Pharmacology
Publisher: SPRINGER/PLENUM PUBLISHERSISSN: 1567-567XFrequency: 6 issues/year

JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, published by Springer/Plenum Publishers, stands as a vital resource in the field of pharmacology. With an ISSN of 1567-567X and an E-ISSN of 1573-8744, this journal is well-regarded within the academic community, as reflected in its Q2 ranking in the 2023 Scopus category for Pharmacology. Spanning years from 1996 to 2024, it serves as a comprehensive platform for cutting-edge research on the interactions of drugs within the body, their effects, and the underlying pharmacological mechanisms. The journal provides a critical avenue for dissemination of significant research findings, with a focus on enhancing understanding in pharmacokinetics, pharmacodynamics, and their implications in therapeutic practices. Targeting an audience of researchers, professionals, and students, the journal emphasizes high-quality manuscripts that contribute to the advancement of knowledge in pharmacology. Although currently not an open access journal, it maintains a strong commitment to promoting scientific communication and collaboration.

Pakistan Journal of Pharmaceutical Sciences

Delivering critical studies that shape the pharmaceutical landscape.
Publisher: UNIV KARACHIISSN: 1011-601XFrequency: 4 issues/year

Pakistan Journal of Pharmaceutical Sciences, published by the University of Karachi, serves as a vital platform for advancing research in the field of pharmaceutical sciences. With a strong commitment to disseminating innovative findings and critical studies since its inception in 1995, the journal focuses on a wide array of topics including pharmacology, toxicology, and pharmaceutics. With an ISSN of 1011-601X, it holds a reputable position within the academic community, reflecting its Q3 category ranking in Pharmaceutical Science as of 2023. While the journal is currently not designated as Open Access, it remains accessible through institutional subscriptions, ensuring that both emerging and established researchers can contribute to and benefit from its scholarly content. This publication not only promotes scientific dialogue but also aims to bridge the gap between academia and industry, appealing to a diverse audience of researchers, professionals, and students seeking to stay informed about the latest advancements and trends in pharmaceutical research.

AAPS PHARMSCITECH

Fostering Collaboration in the Dynamic World of Pharmaceutics
Publisher: SPRINGERISSN: 1530-9932Frequency: 1 issue/year

AAPS PHARMSCITECH is a prestigious peer-reviewed journal published by Springer, focusing on the dynamic field of pharmaceutical sciences and technology. With an ISSN of 1530-9932, it provides a vital platform for disseminating cutting-edge research that spans key areas including drug discovery, pharmacology, toxicology, and ecological impacts of pharmaceuticals. The journal is recognized for its rigorous scientific contributions, currently holding a commendable Q2 quartile ranking across several relevant categories, including Agronomy and Crop Science, Aquatic Science, and Medicine in 2023. Notably, it ranks 43rd out of 183 in the Scopus Pharmacology, Toxicology, and Pharmaceutics category, placing it in the 76th percentile of its field. Aiming to foster innovation and collaboration among researchers, professionals, and students, AAPS PHARMSCITECH is committed to advancing scientific knowledge and addressing contemporary challenges in pharmaceutical sciences. The journal offers various access options to ensure wide dissemination of research findings, making it an essential resource for those dedicated to enhancing public health through pharmaceutical advancements.

PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY

Advancing Pharmaceutical Innovations for a Healthier Tomorrow.
Publisher: TAYLOR & FRANCIS LTDISSN: 1083-7450Frequency: 6 issues/year

PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY is a premier journal published by Taylor & Francis Ltd that focuses on the latest advancements and innovations in the field of pharmaceutical science. Established in 1996, this journal has evolved to encompass a wide array of interdisciplinary studies relevant to drug development, formulation technology, and delivery systems, serving as a platform for researchers and professionals to share groundbreaking findings. With an impressive impact factor and ranked in both Q2 in Pharmaceutical Science and Q3 in Medicine (miscellaneous), it positions itself among the top-tier journals in pharmacology and toxicology. The journal's insights are critical for scholars and practitioners aiming to enhance therapeutic efficacy and safety. Access options for the content remain traditional, thus supporting a comprehensive approach to scientific literature. Throughout its converged years up to 2024, PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY continues to play a vital role in shaping pharmaceutical education and practice.